Intrauterine growth restriction - monitoring and pregnancy outcomes: A narrative review
References
- Sankaran S, Kyle PM. Aetiology and pathogenesis of IUGR. Best Pract Res Clin Obstet Gynaecol. 2009;23(6):765-777.
- Garite TJ, Clark R, Thorp JA. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynaecol. 2004;191(2): 481-487.
- Lees CC, Stampalija T, Baschat A, et al. ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound Obstet Gynaecol. 2020;56(2):298-312.
- American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 204: fetal growth restriction. Obstet Gynaecol. 2019;133(2):e97-e109.
- Chew LC, Osuchukwu OO, Reed DJ, et al. Fetal growth restriction. In StatPearls [Internet]. StatPearls Publishing. 2024.
- Piro E, Serra G, Schierz IAM, Giuffrè M, et al. Fetal growth restriction: a growth pattern with fetal, neonatal and long-term consequences. Euromedit Biomed J. 2019;14(09):38-44.
- Rethlefsen ML, Page MJ. PRISMA 2020 and PRISMA-S: common questions on tracking records and the flow diagram. J Med Libr Assoc. 2022;110(2);253.
- Lees C, Stampalija T, Hecher K. Diagnosis and management of fetal growth restriction: the ISUOG guideline and comparison with the SMFM guideline. Ultrasound Obstet Gynaecol. 2021;57(6):884-887.
- Salomon LJ, Alfirevic Z, da Silva Costa F, et al. ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth. Ultrasound Obstet Gynaecol. 2019; 53:715–723.
- Pilliod RA, Cheng YW, Snowden JM, et al. The risk of intrauterine fetal death in the small-for-gestational-age fetus. Am J Obstet Gynecol. 2012;207:318:e311–316.
- Lees CC, Marlow N, van Wassenaer-Leemhuis A, et al. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet. 2015;385(9983):2162-2172.
- Simonazzi G, Curti A, Cattani L, et al. Outcome of severe placental insufficiency with abnormal umbilical artery Doppler prior to fetal viability. BJOG: Int J Obstet Gynaecol. 2013;120(6):754-757.
- Kujur A, Kashyap S, Xess S, et al. Feto-maternal outcome of oligohydramnios in viable pregnancy. Int J Acad Med Pharm. 2025;7(4):190-195.
- Hu P, Liang D, Chen Y, et al. An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study. J Translat Med. 2019;17(1): 124.
- Zia A, Sahebdel F, Er-Reguyeg Y, et al. Role of Cellular Senescence in IUGR: Impact on Fetal Morbidity and Development. Cells. 2025;14(14):1097.
- Tiagha R, Eteneneng EJ, Gubu-Ntaba N, et al. Intrauterine growth restriction (IUGR) and placental insufficiency: mechanisms and management. Growth. 2022;4:16.
- Mitranovici MI, Chiorean DM, Moraru R, et al. Understanding the pathophysiology of preeclampsia: exploring the role of antiphospholipid antibodies and future directions. J Clin Med. 2024;13(9):2668.
- Pergialiotis V, Prodromidou A, Pappa E, et al. An evaluation of calprotectin as serum marker of preeclampsia: a systematic review of observational studies. Inflamm Res. 2016;65(2):95-102.
- MacDonald TM, Walker SP, Hannan NJ, et al. Clinical tools and biomarkers to predict preeclampsia. E Bio Med. 2022;75:1
- Timofeeva AV, Gusar VA, Kan NE, et al. Identification of potential early biomarkers of preeclampsia. Placenta. 2018;61:61-71.
- Pillay P, Moodley K, Moodley J, et al. Placenta-derived exosomes: potential biomarkers of preeclampsia. Int J Nanomed. 2017;1:8009-8023.
- Sonek J, Krantz D, Carmichael J, et al. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume. Am J Obstet Gynaecol. 2018;218(1):126-e1.
- Kahraman NC, Obut M, Arat O, et al. Association of maternal calprotectin plasma levels with abruption placenta. BMC Pregnancy and Childbirth. 2025;25(1):249.
- Li J, Huang L, Wang S, et al. Increased serum levels of high mobility group protein B1 and calprotectin in pre‐eclampsia. Int J Obstet Gynaecol. 2018;142(1):37-41.
- Rezniczek GA, Foerster C, Hilal Z, et al. Calprotectin in pregnancy and pregnancy-associated diseases: a systematic review and prospective cohort study. Arch Obstet Gynaecol. 2019;299(6):1567-1577.
- Maroudias G, Vrachnis D, Fotiou A, et al. Measurement of Calprotectin and PTH in the Amniotic Fluid of Early Second Trimester Pregnancies and Their Impact on Fetuses with Growth Disorders: Are Their Levels Related to Oxidative Stress?. J Clin Med. 2024;13(3):855.
- Suhag A, Berghella V. Intrauterine growth restriction (IUGR): etiology and diagnosis. Curr Obstet Gynaecol Rep. 2013;2(2):102-111.
- LEE MJ, Conner EL, Charafeddine L, et al. A critical birth weight and other determinants of survival for infants with severe intrauterine growth restriction. Ann NY Acad Scien. 2001;943(1):326-339.
- Visser GH, Bilardo CM, Lees C. Fetal growth restriction at the limits of viability. Fetal Diag Therap. 2014;36(2):162-165.
- Hasmasanu MG, Bolboaca SD, Baizat MI, et al. Neonatal short-term outcomes in infants with intrauterine growth restriction. Saudi Med J. 2015; 36(8):947.
- Baschat AA, Viscardi RM, Hussey-Gardner B, et al. Infant neurodevelopment following fetal growth restriction: relationship with antepartum surveillance parameters. Ultrasound Obstet Gynaecol. 2009;33(1):44-50.
- Priante E, Verlato G, Giordano G, et al. Intrauterine growth restriction: new insight from the metabolomic approach. Metabolites. 2019; 9(11):267.
- Baschat A, Galan H, Bhide A, et al. Viability in early-onset IUGR: is it time to reconsider intervention thresholds?. Am J Obstet Gynaecol.
- Brun JL, Mangione R, Gangbo F, et al. Feasibility, accuracy and safety of chorionic villus sampling: a report of 10 741 cases. Prenatal Diag. 2003;23(4):295-301.
- Herring CM, Bazer FW, Johnson GA, et al. Impacts of maternal dietary protein intake on fetal survival, growth, and development. Exp Biol Med. 2018;243(6):525-533. 2003;189(6):S216.
Language: English
Page range: 3 - 6
Submitted on: Oct 31, 2025
Accepted on: Nov 17, 2025
Published on: Mar 10, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Liviu Moraru, Melinda-Ildiko Mitranovici, Raluca Moraru, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.